These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
874 related items for PubMed ID: 25956624
1. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). Mennuni MG, Halperin JL, Bansilal S, Schoos MM, Theodoropoulos KN, Meelu OA, Sartori S, Giacoppo D, Bernelli C, Moreno PR, Krishnan P, Baber U, Lucarelli C, Dangas GD, Sharma SK, Kini AS, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R. Am J Cardiol; 2015 Jul 01; 116(1):37-42. PubMed ID: 25956624 [Abstract] [Full Text] [Related]
3. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial. Sambola A, Montoro JB, Del Blanco BG, Llavero N, Barrabés JA, Alfonso F, Bueno H, Cequier A, Serra A, Zueco J, Sabaté M, Rodríguez-Leor O, García-Dorado D. Am Heart J; 2013 Oct 01; 166(4):669-75. PubMed ID: 24093846 [Abstract] [Full Text] [Related]
4. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. Chandrasekhar J, Mastoris I, Baber U, Sartori S, Schoos M, Bansilal S, Dangas G, Mehran R. Am Heart J; 2015 Dec 01; 170(6):1234-42. PubMed ID: 26678646 [Abstract] [Full Text] [Related]
5. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GYH. Chest; 2008 Sep 01; 134(3):559-567. PubMed ID: 18641090 [Abstract] [Full Text] [Related]
6. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study. Schlitt A, Rubboli A, Lip GY, Lahtela H, Valencia J, Karjalainen PP, Weber M, Laine M, Kirchhof P, Niemelä M, Vikman S, Buerke M, Airaksinen KE, AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):E864-70. PubMed ID: 23765437 [Abstract] [Full Text] [Related]
7. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Fox KAA, Cohen M. JACC Cardiovasc Interv; 2018 Apr 09; 11(7):626-634. PubMed ID: 29550085 [Abstract] [Full Text] [Related]
8. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation. Ho KW, Ivanov J, Freixa X, Overgaard CB, Osten MD, Ing D, Horlick E, Mackie K, Seidelin PH, Džavík V. Can J Cardiol; 2013 Feb 09; 29(2):213-8. PubMed ID: 23089528 [Abstract] [Full Text] [Related]
9. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML. J Am Coll Cardiol; 2013 Sep 10; 62(11):981-9. PubMed ID: 23747760 [Abstract] [Full Text] [Related]
12. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. Fosbol EL, Wang TY, Li S, Piccini J, Lopes RD, Mills RM, Klaskala W, Thomas L, Roe MT, Peterson ED. Am Heart J; 2013 Nov 10; 166(5):864-70. PubMed ID: 24176442 [Abstract] [Full Text] [Related]
14. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Bavishi C, Koulova A, Bangalore S, Sawant A, Chatterjee S, Ather S, Valencia J, Sarafoff N, Rubboli A, Airaksinen JK, Lip GY, Tamis-Holland JE. Catheter Cardiovasc Interv; 2016 Jul 10; 88(1):E12-22. PubMed ID: 26354765 [Abstract] [Full Text] [Related]
15. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy. Desai A, Escamilla-Ocanas C, Dilip D, Saber H, Damani R. J Stroke Cerebrovasc Dis; 2021 Apr 10; 30(4):105654. PubMed ID: 33578352 [Abstract] [Full Text] [Related]
18. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Mishra A, Singh M, Acker WW, Kamboj S, Sporn D, Stapleton D, Kaluski E. J Cardiovasc Pharmacol; 2019 Aug 10; 74(2):82-90. PubMed ID: 31306367 [Abstract] [Full Text] [Related]
19. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention. Kiviniemi T, Karjalainen P, Rubboli A, Schlitt A, Tuomainen P, Niemelä M, Laine M, Biancari F, Lip GY, Airaksinen KE. Am J Cardiol; 2013 Aug 15; 112(4):493-8. PubMed ID: 23672991 [Abstract] [Full Text] [Related]
20. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemelä M, Lip GY, Airaksinen KE. Thromb Res; 2014 Apr 15; 133(4):560-6. PubMed ID: 24461143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]